<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30356316</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>10</Issue><PubDate><Year>2018</Year><Month>Oct</Month></PubDate></JournalIssue><Title>PLoS neglected tropical diseases</Title><ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation></Journal><ArticleTitle>Seroprevalence of dengue virus in two districts of Kaohsiung City after the largest dengue outbreak in Taiwan since World War II.</ArticleTitle><Pagination><StartPage>e0006879</StartPage><MedlinePgn>e0006879</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0006879</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0006879</ELocationID><Abstract><AbstractText>Dengue virus (DENV) is the leading cause of arboviral diseases in humans worldwide. In this study, we investigated the seroprevalence of DENV infection in two districts of Kaohsiung City, a metropolis in southern Taiwan, where major dengue outbreaks have occurred in the past three decades. We enrolled 1,088 participants from the Sanmin and Nanzih districts after the dengue outbreak of 2015, the largest in Taiwan since World War II, and found an overall DENV seroprevalence of 12.4% (95% confidence interval: 10.5-13.4%) based on the InBios DENV IgG ELISA kit. The ratios of clinically inapparent to symptomatic infections were 2.86 and 4.76 in Sanmin and Nanzih districts, respectively. Consistent with higher case numbers during recent outbreaks, the DENV seroprevalence was higher in Sanmin district (16.4%) than in Nanzih district (6.9%), suggesting district differences in seroprevalence and highlighting the importance of screening the DENV immune status of each individual before using the currently available DENV vaccine, Dengvaxia. In the two districts, the seroprevalence rates increased from 2.1% (in the 30-39-year age group) to 17.1% (60-69) and 50% (70-79). The pattern of a sharp and significant increase in seroprevalence in the 70-79-year age group correlated with a dramatic increase in the proportion of clinically severe DENV infections among total dengue cases in that age group. This differed from observations in the Americas and Southeast Asia and suggested that a large proportion of monotypically immune individuals together with other risk factors may contribute to clinically severe dengue among the elderly in Taiwan.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Jih-Jin</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Tropical Medicine Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ching-Kuan</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Center for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Wen-Yang</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Li-Teh</ForeName><Initials>LT</Initials><AffiliationInfo><Affiliation>Department of Medical Laboratory Science and Biotechnology, College of Medicine and Life Science, Chung-Hwa University of Medical Technology, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tyson</LastName><ForeName>Jasmine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsai</LastName><ForeName>Ching-Yi</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Tropical Medicine Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Ping-Chang</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Tropical Medicine Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Wei-Kung</ForeName><Initials>WK</Initials><Identifier Source="ORCID">0000-0002-6670-4663</Identifier><AffiliationInfo><Affiliation>Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AI110769</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI149502</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Negl Trop Dis</MedlineTA><NlmUniqueID>101291488</NlmUniqueID><ISSNLinking>1935-2727</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007074">Immunoglobulin G</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000367" MajorTopicYN="N">Age Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002947" MajorTopicYN="N" Type="Geographic">Cities</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004797" MajorTopicYN="N">Enzyme-Linked Immunosorbent Assay</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007074" MajorTopicYN="N">Immunoglobulin G</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016036" MajorTopicYN="N">Seroepidemiologic Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013624" MajorTopicYN="N" Type="Geographic">Taiwan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019371" MajorTopicYN="N">Topography, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>I have read the journal&#x2019;s policy and the authors of this manuscript have the following competing interests: The DENV detect IgG ELISA kits were kindly provided by Dr. Syamal Raychaudhuri at InBios International, Inc. Seattle.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30356316</ArticleId><ArticleId IdType="pmc">PMC6218099</ArticleId><ArticleId IdType="doi">10.1371/journal.pntd.0006879</ArticleId><ArticleId IdType="pii">PNTD-D-18-00101</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Guzman MG, Harris E. Dengue. Lancet. 2015;385:453&#x2013;465. 10.1016/S0140-6736(14)60572-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(14)60572-9</ArticleId><ArticleId IdType="pubmed">25230594</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504&#x2013;507. 10.1038/nature12060</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. 2009. Dengue hemorrhagic fever: Diagnosis, treatment, prevention and control. 3rd ed, Geneva, Switzerland.</Citation></Reference><Reference><Citation>Halstead SB. Pathogenesis of dengue: challenges to molecular biology. Science. 1988;239: 476&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pubmed">3277268</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz LM, Halloran ME, Durbin AP, Longini IM Jr. The dengue vaccine pipeline: Implications for the future of dengue control. Vaccine. 2015;33:3293&#x2013;3298. 10.1016/j.vaccine.2015.05.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.05.010</ArticleId><ArticleId IdType="pmc">PMC4470297</ArticleId><ArticleId IdType="pubmed">25989449</ArticleId></ArticleIdList></Reference><Reference><Citation>Guy B, Briand O, Lang J, Saville M, Jackson N. Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward. Vaccine. 2015;33:7100&#x2013;7111. 10.1016/j.vaccine.2015.09.108</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.09.108</ArticleId><ArticleId IdType="pubmed">26475445</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadinegoro SR, Arredondo-Garc&#xed;a JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, et al. Efficacy and long-term safety of a dengue vaccine in regions of endemic disease. N Engl J Med. 2015;373:1195&#x2013;1206. 10.1056/NEJMoa1506223</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1506223</ArticleId><ArticleId IdType="pubmed">26214039</ArticleId></ArticleIdList></Reference><Reference><Citation>Deen J. The Dengue vaccine dilemma: balancing the individual and population risks and benefits. PLoS Med. 2016;13:e1002182 10.1371/journal.pmed.1002182</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002182</ArticleId><ArticleId IdType="pmc">PMC5127493</ArticleId><ArticleId IdType="pubmed">27898675</ArticleId></ArticleIdList></Reference><Reference><Citation>Sridhar S, Luedtke A, Langevin E, Zhu M, Bonaparte M, Machabert T, et al. Effect of dengue serostatus on dengue vaccine safety and efficacy. N Engl J Med. 2018. June 13 10.1056/NEJMoa1800820 [Epub ahead of print]</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1800820</ArticleId><ArticleId IdType="pubmed">29897841</ArticleId></ArticleIdList></Reference><Reference><Citation>Normile D. Safety concerns derail dengue vaccination program. Science. 2017; 358:1514&#x2013;5. 10.1126/science.358.6370.1514</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.358.6370.1514</ArticleId><ArticleId IdType="pubmed">29269451</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacobucci G. WHO recommends additional tests for Sanofi&#x2019;s dengue vaccine after safety concerns. BMJ. 2018; 20:361.</Citation><ArticleIdList><ArticleId IdType="pubmed">29678901</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu YC. Epidemic dengue 2 on Liouchyou Shiang, Pingtung County in 1981. J Microbiol Immunol Infect. 1986;19:203&#x2013;211.</Citation><ArticleIdList><ArticleId IdType="pubmed">3816365</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang JH, Liao TL, Chang SF, Su CL, Chien LJ, Kuo YC, et al. Laboratory-based dengue surveillance in Taiwan, 2005: a molecular epidemiologic study. Am J Trop Med Hyg. 2007;77:903&#x2013;909.</Citation><ArticleIdList><ArticleId IdType="pubmed">17984351</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CC, Huang YH, Shu PY, Wu HS, Lin YS, Yeh TM, et al. Characteristic of dengue disease in Taiwan: 2002&#x2013;2007. Am J Trop Med Hyg. 2010;82:731&#x2013;739. 10.4269/ajtmh.2010.09-0549</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2010.09-0549</ArticleId><ArticleId IdType="pmc">PMC2844571</ArticleId><ArticleId IdType="pubmed">20348527</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HL, Lin SR, Liu HF, King CC, Hsieh SC, Wang WK. Evolution of dengue virus type 2 during two consecutive outbreaks with an increase in severity in southern Taiwan in 2001&#x2013;2. Am J Trop Med Hyg. 2008;79:495&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">18840735</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SF, Yang CF, Hsu TC, Su CL, Lin CC, Shu PY. Laboratory-based surveillance and molecular characterization of dengue viruses in Taiwan, 2014. Am J Trop Med Hyg. 2016;94:804&#x2013;811. 10.4269/ajtmh.15-0534</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.15-0534</ArticleId><ArticleId IdType="pmc">PMC4824222</ArticleId><ArticleId IdType="pubmed">26880779</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang SF, Chang K, Loh EW, Wang WH, Tseng SP, Lu PL, et al. Consecutive large dengue outbreaks in Taiwan in 2014&#x2013;2015. Emerg Microbes Infect. 2016; 5:e123 10.1038/emi.2016.124</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2016.124</ArticleId><ArticleId IdType="pmc">PMC5180368</ArticleId><ArticleId IdType="pubmed">27924810</ArticleId></ArticleIdList></Reference><Reference><Citation>Taiwan National Infectious Disease Statistics System, https://nidss.cdc.gov.tw/ch/SingleDisease.aspx?dc=1&amp;dt=2&amp;disease=061.</Citation></Reference><Reference><Citation>Shu PY, Chang SF, Yueh YY, Chow L, Chien LJ, Kuo YC, et al. Current status of dengue diagnosis at the Center for Disease Control, Taiwan. Dengue Bull. 2004; 28:107&#x2013;117.</Citation></Reference><Reference><Citation>McKerr C, Lo YC, Edeghere O, Bracebridge S. Evaluation of the national Notifiable Diseases Surveillance System for dengue fever in Taiwan, 2010&#x2013;2012. PLoS Negl Trop Dis. 2015;9:e0003639 10.1371/journal.pntd.0003639</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003639</ArticleId><ArticleId IdType="pmc">PMC4368052</ArticleId><ArticleId IdType="pubmed">25794177</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WJ, King CC, Chien LY, Chen SL, Fang AH. Changing prevalence of antibody to Dengue virus in paired sera in the two years following an epidemic in Taiwan. Epidemiol Infect. 1997;119:277&#x2013;279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2808851</ArticleId><ArticleId IdType="pubmed">9363028</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaohsiung city government: https://www.kcg.gov.tw/cp.aspx?n=07880B28C8E3EAEA</Citation></Reference><Reference><Citation>Tsai WY, Durbin A, Tsai JJ, Whitehead S, Wang WK. Complexity of neutralization antibodies against multiple dengue viral serotypes after heterotypic immunization and secondary infection revealed by in-depth analysis of cross-reactive antibodies. J Virol. 2015;89:7348&#x2013;7362. 10.1128/JVI.00273-15</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00273-15</ArticleId><ArticleId IdType="pmc">PMC4473561</ArticleId><ArticleId IdType="pubmed">25972550</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai WY, Youn HH, Brites C, Tsai JJ, Tyson JJ, Pedroso C, et al. Distinguishing secondary dengue virus infection from Zika virus infection with previous dengue by combination of three simple serological tests. Clin Infect Dis. 2017;65:1829&#x2013;1836. 10.1093/cid/cix672</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix672</ArticleId><ArticleId IdType="pmc">PMC5850648</ArticleId><ArticleId IdType="pubmed">29020159</ArticleId></ArticleIdList></Reference><Reference><Citation>Namekar M, Kumar M, O&#x2019;Connell M, Nerurkar VR. Effect of serum heat-inactivation and dilution on detection of anti-WNV antibodies in mice by West Nile virus E-protein microsphere immunoassay. PLoS One. 2012;7:e45851 10.1371/journal.pone.0045851</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0045851</ArticleId><ArticleId IdType="pmc">PMC3457982</ArticleId><ArticleId IdType="pubmed">23049879</ArticleId></ArticleIdList></Reference><Reference><Citation>Paldanius M, Bloigu A, Leinonen M, Saikku P. Measurement of chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one enzyme immunoassay kit. Clin Diagn Lab Immunol. 2003;10:8&#x2013;12. 10.1128/CDLI.10.1.8-12.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CDLI.10.1.8-12.2003</ArticleId><ArticleId IdType="pmc">PMC145278</ArticleId><ArticleId IdType="pubmed">12522032</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu LC, Chen YJ, Hsu FK, Huang JH, Chang CM, Chou P, et al. The incidence of Japanese encephalitis in Taiwan&#x2014;a population-based study. PLoS Negl Trop Dis. 2014;8:e3030 10.1371/journal.pntd.0003030</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003030</ArticleId><ArticleId IdType="pmc">PMC4109885</ArticleId><ArticleId IdType="pubmed">25058573</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng HF, Tan HF, Chang CK, Huang WL, Ho WC. Seroepidemiology study of Japanese encephalitis neutralizing antibodies in southern Taiwan: a comparative study between urban city and country townships. Am J Infect Control. 2003;31:435&#x2013;440. 10.1067/mic.2003.73</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/mic.2003.73</ArticleId><ArticleId IdType="pubmed">14639442</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu YC, Huang YS, Chien LJ, Lin TL, Yueh YY, et al. The epidemiology of Japanese encephalitis on Taiwan during 1966&#x2013;1997. Am J Trop Med Hyg. 1999; 61:78&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">10432061</ArticleId></ArticleIdList></Reference><Reference><Citation>Innis BL. 1997. Antibody responses to dengue virus infection In Gubler DJ, Kuno G eds: Dengue and dengue hemorrhagic fever. Cambridge, MA: CAB International, pp. 221&#x2013;44.</Citation></Reference><Reference><Citation>Johnson BW, Kosoy O, Martin DA, Noga AJ, Russell BJ, Johnson AA, et al. West Nile virus infection and serologic response among persons previously vaccinated against yellow fever and Japanese encephalitis viruses. Vector Borne Zoonotic Dis. 2005; 5:137&#x2013;145. 10.1089/vbz.2005.5.137</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/vbz.2005.5.137</ArticleId><ArticleId IdType="pubmed">16011430</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiou SS, Crill WD, Chen LK, Chang GJ. Enzyme-linked immunosorbent assays using novel Japanese encephalitis virus antigen improve the accuracy of clinical diagnosis of flavivirus infections. Clin Vaccine Immunol. 2008;15:825&#x2013;835. 10.1128/CVI.00004-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00004-08</ArticleId><ArticleId IdType="pmc">PMC2394851</ArticleId><ArticleId IdType="pubmed">18337381</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang J, Hsu JP, Yeo TW, Leo YS, Lye DC. Diabetes, cardiac disorders and asthma as risk factors for severe organ involvement among adult dengue patients: A matched case-control study. Sci Rep. 2017;7:39872 10.1038/srep39872</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep39872</ArticleId><ArticleId IdType="pmc">PMC5206669</ArticleId><ArticleId IdType="pubmed">28045096</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowe EK, Leo YS, Wong JG, Thein TL, Gan VC, Lee LK, et al. Challenges in dengue fever in the elderly: atypical presentation and risk of severe dengue and hospital-acquired infection. PLoS Negl Trop Dis. 2014;8:e2777 10.1371/journal.pntd.0002777</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002777</ArticleId><ArticleId IdType="pmc">PMC3974675</ArticleId><ArticleId IdType="pubmed">24699282</ArticleId></ArticleIdList></Reference><Reference><Citation>Pang J, Salim A, Lee VJ, Hibberd ML, Chia KS, Leo YS, et al. Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study. PLoS Negl Trop Dis. 2012;6:e1641 10.1371/journal.pntd.0001641</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001641</ArticleId><ArticleId IdType="pmc">PMC3341340</ArticleId><ArticleId IdType="pubmed">22563519</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei HY, Shu PY, Hung MN. Characteristics and risk factors for fatality in patients with dengue hemorrhagic fever, Taiwan, 2014. Am J Trop Med Hyg, 2016;95:322&#x2013;327. 10.4269/ajtmh.15-0905</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.15-0905</ArticleId><ArticleId IdType="pmc">PMC4973177</ArticleId><ArticleId IdType="pubmed">27273649</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang K, Huang CH, Lee IK, Lu PL, Lin CY, Chen TC, et al. Differences in mortality and clinical manifestations of dengue hemorrhagic fever in Taiwan in different years: a comparison for cases in 2014 and 2015 epidemics. Am J Trop Med Hyg. 2017; 97:361&#x2013;368. 10.4269/ajtmh.16-1018</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.16-1018</ArticleId><ArticleId IdType="pmc">PMC5544090</ArticleId><ArticleId IdType="pubmed">28722609</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh CC, Cia CT, Lee JC, Sung JM, Lee NY, Chen PL, et al. A cohort study of adult patients with severe dengue in Taiwanese intensive care units: the elderly and APTT prolongation matter for prognosis. PLoS Negl Trop Dis. 2017; 11:e0005270 10.1371/journal.pntd.0005270</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0005270</ArticleId><ArticleId IdType="pmc">PMC5245902</ArticleId><ArticleId IdType="pubmed">28060934</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya M, Gresh L, Mercado JC, Williams KL, Vargas MJ, Gutierrez G, et al. Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year. PLoS Negl Trop Dis. 2013;7:e2357 10.1371/journal.pntd.0002357</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002357</ArticleId><ArticleId IdType="pmc">PMC3738476</ArticleId><ArticleId IdType="pubmed">23951377</ArticleId></ArticleIdList></Reference><Reference><Citation>Balmaseda A, Mercado JC, Matute JC, Tellez Y, Sabor&#xed;o S, et al. Trends in patterns of dengue transmission in a pediatric cohort study in Nicaragua. J Infect Dis. 2010;201:5&#x2013;14. 10.1086/648592</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/648592</ArticleId><ArticleId IdType="pmc">PMC3724236</ArticleId><ArticleId IdType="pubmed">19929380</ArticleId></ArticleIdList></Reference><Reference><Citation>Endy TP, Anderson KB, Nisalak A, Yoon IK, Green S, et al. Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. PLoS Negl Trop Dis. 2011;5:e975 10.1371/journal.pntd.0000975</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000975</ArticleId><ArticleId IdType="pmc">PMC3046956</ArticleId><ArticleId IdType="pubmed">21390158</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon IK, Rothman AL, Tannitisupawong D, Srikiatkhachorn A, Jarman RG, et al. Underrecognized mildly symptomatic viremic dengue virus infections in rural thai schools and villages. J Infect Dis. 2012;206:389&#x2013;398. 10.1093/infdis/jis357</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jis357</ArticleId><ArticleId IdType="pmc">PMC3490697</ArticleId><ArticleId IdType="pubmed">22615312</ArticleId></ArticleIdList></Reference><Reference><Citation>Dussart P, Baril L, Petit L, Beniguel L, Quang LC, et al. Clinical and virological study of dengue cases and the members of their households: the multinational DENFRAME Project. PLoS Negl Trop Dis. 2012;6:e1482 10.1371/journal.pntd.0001482</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001482</ArticleId><ArticleId IdType="pmc">PMC3265457</ArticleId><ArticleId IdType="pubmed">22292098</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison AC, Minnick SL, Rocha C, Forshey BM, Stoddard ST, Getis A, et al. Epidemiology of dengue virus in Iquitos, Peru 1999 to 2005: interepidemic and epidemic patterns of transmission. PLoS Negl Trop Dis. 2010;4:e670 10.1371/journal.pntd.0000670</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000670</ArticleId><ArticleId IdType="pmc">PMC2864256</ArticleId><ArticleId IdType="pubmed">20454609</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Barraquer I, Cordeiro MT, Braga C, de Souza WV, Marques ET, Cummings DA. From re-emergence to hyperendemicity: the natural history of the dengue epidemic in Brazil. PLoS Negl Trop Dis. 2011;5:e935 10.1371/journal.pntd.0000935</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000935</ArticleId><ArticleId IdType="pmc">PMC3014978</ArticleId><ArticleId IdType="pubmed">21245922</ArticleId></ArticleIdList></Reference><Reference><Citation>Anders KL, Nguyet NM, Chau NV, Hung NT, Thuy TT, Lien le B, et al. Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam. Am J Trop Med Hyg. 2011;84:127&#x2013;134. 10.4269/ajtmh.2011.10-0476</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2011.10-0476</ArticleId><ArticleId IdType="pmc">PMC3005500</ArticleId><ArticleId IdType="pubmed">21212214</ArticleId></ArticleIdList></Reference><Reference><Citation>Guzm&#xe1;n MG, Kouri G, Bravo J, Valdes L, Vazquez S, Halstead SB. Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis. 2002;6:118&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">12121599</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB, Russell PK. Protective and immunological behavior of chimeric yellow fever dengue vaccine. Vaccine. 2016;34:1643&#x2013;1647. 10.1016/j.vaccine.2016.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.02.004</ArticleId><ArticleId IdType="pubmed">26873054</ArticleId></ArticleIdList></Reference><Reference><Citation>Teixeira MG, Costa MC, Coelho G, Barreto ML. Recent shift in age pattern of dengue hemorrhagic fever, Brazil. Emerg Infect Dis. 2008;14:1663 10.3201/eid1410.071164</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1410.071164</ArticleId><ArticleId IdType="pmc">PMC2609867</ArticleId><ArticleId IdType="pubmed">18826842</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcanti LP, Vilar D, Souza-Santos R, Teixeira MG. Change in age pattern of persons with dengue, northeastern Brazil. Emerg Infect Dis. 2011;17:132&#x2013;134. 10.3201/eid1701.100321</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid1701.100321</ArticleId><ArticleId IdType="pmc">PMC3204623</ArticleId><ArticleId IdType="pubmed">21192876</ArticleId></ArticleIdList></Reference><Reference><Citation>Thai KT, Binh TQ, Giao PT, Phuong HL, Hung le Q, Van Nam N, et al. Seroprevalence of dengue antibodies, annual incidence and risk factors among children in southern Vietnam. Trop Med Int Health. 2005;10:379&#x2013;386. 10.1111/j.1365-3156.2005.01388.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-3156.2005.01388.x</ArticleId><ArticleId IdType="pubmed">15807802</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Cutter J, James L, Goh KT. Seroepidemiology of dengue virus infection in the adult population in tropical Singapore. Epidemiol Infect. 2015;143:1585&#x2013;1593. 10.1017/S0950268814002507</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268814002507</ArticleId><ArticleId IdType="pubmed">25245094</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang LW, Cutter J, James L, Goh KT. Seroprevalence of past dengue virus infection among children and adolescents in Singapore. J Med Virol. 2015;87:2159&#x2013;2162. 10.1002/jmv.24287</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24287</ArticleId><ArticleId IdType="pubmed">26058712</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques FZ, Mackay CR, Kaye DM. Beyond gut feelings: how the gut microbiota regulates blood pressure. Nat Rev Cardiol. 2018;15:20&#x2013;32. 10.1038/nrcardio.2017.120</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2017.120</ArticleId><ArticleId IdType="pubmed">28836619</ArticleId></ArticleIdList></Reference><Reference><Citation>Thackray LB, Handley SA, Gorman MJ, Poddar S, Bagadia P, Brise&#xf1;o CG, et al. Oral antibiotic treatment of mice exacerbates the disease severity of multiple flavivirus infections. Cell Rep. 2018;22:3440&#x2013;3453. 10.1016/j.celrep.2018.03.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.03.001</ArticleId><ArticleId IdType="pmc">PMC5908250</ArticleId><ArticleId IdType="pubmed">29590614</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Health and Welfare Taiwan, Health Promotion Administration. https://www.hpa.gov.tw/EngPages/Index.aspx</Citation></Reference><Reference><Citation>Guzm&#xe1;n MG, Kouri G, Valdes L, Bravo J, Alvarez M, Vazques S, et al. Epidemiologic studies on dengue in Santiago de Cuba, 1997. Am J Epidemiol. 2000; 152:793&#x2013;799.</Citation><ArticleIdList><ArticleId IdType="pubmed">11085389</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>